Just co-authored: Retinal oximetry may further the understanding of common vascular and ischemic disorders, including glaucoma, diabetic retinopathy, vein occlusions… Retinal oximetry in glaucoma: investigations and findings reviewed https://t.co/HQFJg48dAC Source by Thomas Ciulla, MD, MBA Return to main website.
Month: April 2020
Fauci on remdesivir for COVID-19: ‘This will be the standard of care’ https://t.co/iNKIdA4zS7 Source by Thomas Ciulla, MD, MBA Return to main website.
Risks of turning to homemade cleaning products amid COVID-19 https://t.co/KM0I7018BA Source by Thomas Ciulla, MD, MBA Return to main website.
RT @ophthopedia: Ophthopedia Update: Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Pha… Source by Thomas Ciulla, MD, MBA Return to main website.
Just published….Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases… https://t.co/f25J5fPLea Source by Thomas Ciulla, MD, MBA Return to main website.
Diabetic macular edema, a leading cause of vision loss, is treated less intensely and shows worse outcomes than in clinical trials.
Just published… Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular edema: a real-world analysis of 28 658 patient eyes
Just published…This first FDA-approved gene therapy for a hereditary genetic disease, marks a new cycle of therapeutic innovation, especially for inherited retinal disease & potentially for common disorders, such as AMD & diabetic retinopathy.